基本説明
This 1983 book reports the proceedings of the eleventh European symposium on clinical pharmacy which was held in Brussels in October 1982. The theme of the symposium was the concept of the therapeutic team and the relative contributions and responsibilities of pharmacists, nurses and physicians to the planning and implementation of drug treatment regimens.
Full Description
This 1983 book reports the proceedings of the eleventh European symposium on clinical pharmacy which was held in Brussels in October 1982. The theme of the symposium was the concept of the therapeutic team and the relative contributions and responsibilities of pharmacists, nurses and physicians to the planning and implementation of drug treatment regimens. The first section of the volume provides an introduction to the concept of the therapeutic team and reflects the views several medical professionals. The later sections cover the practice of the therapeutic team in parenteral nutrition, oncology, dermatology, epilepsy, internal medicine, nuclear medicine and drug selection. Not only did this book review achievements and experiences in clinical pharmacy, but it also looked towards the future of clinical pharmacy development in Europe. It will still be of significant interest to clinical pharmacy specialists today.
Contents
Preface; Part I. Introduction: 1. Introductory remarks; Part II. The Concept of the Theraputic Team: 2. The concept of the therapeutic team; 3. The view of a pharmacist; 4. The view of a physician; 5. The view of a nurse; 6. The view of the clinical pharmacologist; 7. The view of an academic; Part III. Practice of the Therapeutic Team: Parenteral Nutrition: 8. Parenteral nutrition - the team approach in a general hospital; 9. Long-term follow-up in total parenteral nutrition; 10. Total parenteral nutrition of children at the State University Hospital of Copenhagen; 11. Compatibility of two different fat emulsions with amino-acids, carbohydrate and electrolytes in parenteral nutrition mixtures; 12. Esophagus cancer and parenteral nutrition: postoperative complications and P. N. I. relationship. Preliminary study; Part IV. Oncology: 13. Central nervous system prohylaxis of acute lymphoblastic leukemia with methotrexate; 14. The treatment protocols of acute lymphoblastic leukemia in children; 15. Guidelines for the safe handling of minibags; 16. Centralization of preparation of cytotoxic drugs in the central pharmacy: one year of experience; 17. Progress in the management of high dose methotrexate; 18. Parmacokinetics of cytosine arabinoside in leukemic patients with normal and impaired hepatic functions, preliminary results; PartV. Dermatology: 19. The operation of a therapeutic team in dermatology; Part VI. Epilepsy: 20. Team treatment of epilepsy; 21. Practices of the therapeutic team in epilepsy; 22. Interdisciplinary approach to the treatment of epilepsy; 23. The role of clinical pharmacist in the monitoring of antiepileptic therapy in clinics with ambulant patients, our experience with 45 patients; Part VII. Internal Medicine - Rheumatology: 24. An approach to the therapeutic strategy in rheumatoid arthritis. Adverse reactions to penicillamine-like drugs used in the treatment of rheumatoid arthritis; Part VIII. Nuclear Medicine: 25. The nuclear medicine team; 26. Practice of the nuclear medicine therapeutic team: the role of the physician; 27. Practice of the nuclear medicine therapeutic team: the role of the physicist; 28. Practice of the nuclear medicine therapeutic team: the role of the radiotherapist; Part IX. Drug Selection: 29. Collaboration in drug selection - preparing the London Hospital Formulary 1982 - guide to the prescribing of medicines: introduction; 30. A clinician's view on the team approach to drug selection; 31. A pharmacists view on the team approach to drug selection; 32. Conclusion; 33. Restrictive formulary management with consequences for the treatment of individual patients; 34. Changes in patterns of analgesic use; Part X. Pharmacokinetics, Dialysis, I. V. Therapy: 35. Clinical pharmacy improvement and interrelation with therapeutci team; 36. Clinical pharmacist participation in a clinical trial - treatment of congestive heart failure; 37. Metronidazole plasma levels after I. V. and rectal administration; 38. Individual factors influencing aminoglycoside serum levels; 39. Monitoring theophylline plasma levels; 40. Comparison of four pharmacokinetic methods for individualizing phenytoin dosage; 41. Use of a calculator program for individualized estimation of pheyoin kinetic parameters by a least-squares technique; 42. On the importance of regular Al determination in patients on regular hemodialysis (RHD); 43. Manufacture of dialysis concentrate at the level of a hospital; 44. Hospital preparation of injectable drugs by means of a multi-additive pump; 45. How to detect physico-chemical incompatabilities in I. V. admixtures; 46. Preparation of an enema containing metaminosalicylic acid
